Invention Grant
- Patent Title: Peptides
-
Application No.: US14910372Application Date: 2014-08-06
-
Publication No.: US09938329B2Publication Date: 2018-04-10
- Inventor: David Wraith
- Applicant: APITOPE INTERNATIONAL NV
- Applicant Address: BE Diepenbeek
- Assignee: APITOPE INTERNATIONAL NV
- Current Assignee: APITOPE INTERNATIONAL NV
- Current Assignee Address: BE Diepenbeek
- Agency: Marshall, Gerstein & Borun LLP
- Priority: GB1314052.0 20130806
- International Application: PCT/IB2014/063739 WO 20140806
- International Announcement: WO2015/019302 WO 20150212
- Main IPC: A61K38/16
- IPC: A61K38/16 ; C07K14/47 ; A61K39/00 ; C07K14/72 ; C07K7/08 ; A61K38/00
Abstract:
The present invention provides a peptide at least partially derivable from human Thyroid Stimulating Hormone Receptor (TSHR) which peptide is capable of binding to an MHC molecule in vitro and being presented to a T cell without further antigen processing. The present invention also relates to the use of such peptides for the prevention or suppression of activating autoantibody formation in Graves' Disease.
Public/Granted literature
- US20160185833A1 PEPTIDES Public/Granted day:2016-06-30
Information query
IPC分类:
